AZ Centers Pearl As The Jewel Of Its Respiratory Franchise
The British pharma announced its proposed acquisition of Pearl Therapeutics, adding a late-stage COPD drug to its pipeline and a triple combo therapy to its mid-stage pipeline.
The British pharma announced its proposed acquisition of Pearl Therapeutics, adding a late-stage COPD drug to its pipeline and a triple combo therapy to its mid-stage pipeline.